Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday.

The Dow traded up 1.63% to 30,116.47 while the NASDAQ rose 3.01% to 10,631.71. The S&P 500 also rose, gaining, 2.41% to 3,669.36.

Also check this: Market Volatility Declines Following US Inflation Data

Leading and Lagging Sectors

Real estate shares climbed 3.9% on Monday. Leading the sector was strength from Seritage Growth Properties SRG and Doma Holdings Inc. DOMA.

In trading on Monday, consumer staples shares rose by just 1.2%.

Top Headline


Bank of America BAC reported better-than-expected Q3 results.

Bank of America posted quarterly earnings of $0.81 per share, topping market estimates of $0.77 per share. The bank’s quarterly sales came in at $24.50 billion, exceeding expectations of $23.60 billion.


Equities Trading UP


  • Acorda Therapeutics, Inc. ACOR shares shot up 81% to $0.62 after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
  • Shares of Archaea Energy Inc. LFG got a boost, shooting 53% to $25.83 after the company announced it will be acquired by BP for approximately $4.1 billion.
  • Babylon Holdings Limited BBLN shares were also up, gaining 30% to $0.4803 after reporting a private placement financing.

Equities Trading DOWN

  • NGM Biopharmaceuticals, Inc. NGM shares tumbled 73% to $3.13 after the company announced topline efficacy and safety results from its CATALINA Phase 2 trial of NGM621 for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Over 52 weeks of treatment, NGM621 administered every four weeks (Q4W) (n=108) and every eight weeks (Q8W) (n=104) demonstrated a GA lesion area reduction of 6.3% and 6.5%, respectively, compared to sham (n=106), which did not reach statistical significance in either arm.
  • Shares of Fox Corporation FOX were down 7% to $26.98 after the company said it formed a special committee to explore a potential combination with News Corporation.
  • Minerva Neurosciences, Inc. NERV was down, falling 61% to $5.25 after the company received a refusal to file letter from the FDA regarding its marketing application for roluperidone for negative symptoms in patients with schizophrenia.

Also check out: Fear Among US Investors Increases After Dow Dips 400 Points


In commodity news, oil traded up 0.8% to $86.30, while gold traded up 1.1% at $1,667.40.

Silver traded up 3% to $18.62 on Monday while copper fell 0.2% to $3.4170.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 1.86%, London’s FTSE 100 rose 0.99% while Spain’s IBEX 35 Index jumped 2.41%. The German DAX climbed 1.7%, French CAC 40 rose 1.79% and Italy’s FTSE MIB Index gained 1.83%.

The annual inflation rate in Italy accelerated to 8.9% in September, the highest level in around 37 years, compared to 8.4% in the prior month.



The NY Empire State Manufacturing Index fell 7.6 points to -9.1 in October, versus market estimates of -4.0.

Check out this: Ethereum Surpasses This Major Level; Here Are The Top Crypto Movers For Monday

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,850,120 cases with around 1,090,530 deaths. India confirmed a total of at least 44,630,880 cases and 528,900 deaths, while France reported over 36,258,600 COVID-19 cases with 155,810 deaths. In total, there were at least 630,019,300 cases of COVID-19 worldwide with more than 6,571,720 deaths.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!